Retina Global Logo
  • Home
  • News
  • About
    • Objectives
    • Board
    • Advisory Board
  • Projects
    • Orange County Eye Project
      • OCEP Clinic – Oct 23, 2021
      • OCEP Clinic & Inauguration – Sep 25, 2021
      • Previous OCEP clinics
        • Clinic – Aug 8, 2021
        • Clinic – July 10, 2021
        • Clinic – June 12, 2021
    • Burundi
    • Belize
    • Bolivia
      • Bolivian Diabetic Retinopathy (#BOLDR) Project
      • Volunteer Retina Specialists for #BOLDR project
      • #BOLDR Curso de Certificación en Retinopatía Diabética
      • #BOLDR Certification Course in Diabetic Retinopathy
    • Bahamas
    • Haiti
    • Future projects
  • Knowledge
  • Join us
  • Support us

Category Archives: Pharmaceuticals/Drugs

Amy Millen

AMD likely to be more in people with deficient vitamin D status

Posted on August 28, 2015August 28, 2015 by RetinaGlobal

A multi-institutional team reports that vitamin D may play a significant role in eye health, specifically in the possible prevention of age-related macular degeneration, or AMD, among women who are more genetically prone to developing the sight-damaging disease. In a paper published in JAMA Ophthalmology online, the team found that women who are deficient in

READ MORE…

New drugs in the pipeline target novel pathways for treatment of diabetic retinopathy

Posted on January 18, 2015January 18, 2015 by admin

There is exciting on-going research in the field of treatments for patients with diabetic macular edema (DME). There is a long list of drugs in the pipeline for treating this disease that affects a significant number of people around the world. Pipeline drugs target novel pathways to treat diabetic eye disease. Among promising pipeline drugs

READ MORE…

Post navigation

« Previous 1 2
Retina Global

Location

PO Box 8012, Laguna Hills, CA 92654
USA

Contact

Phone: +1-949-281-6768

Email: info@retinaglobal.org

Policies

Legal
Advertisements
Disclaimer

© Retina Global 2012-2023. All rights reserved.
// © 2012-2023